Suggestions
Aashish Bapat
MedTech I Product Management & Marketing I ex Bain & Co
Aashish Bapat is a Group Product Manager at Stryker, specifically overseeing Global Marketing for Hemorrhagic Stroke, which includes both upstream and downstream product management. He has approximately 12 years of experience in the MedTech industry, where he has successfully guided two PMA (Premarket Approval) products through their full new product development (NPD) lifecycle and led significant marketing initiatives.12
Education and Skills
Aashish Bapat holds a degree from the Wharton School of the University of Pennsylvania, which is renowned for its business programs. His expertise lies in product management and marketing within the medical technology sector, focusing on innovative solutions for hemorrhagic stroke treatment.1
Professional Background
In his current role at Stryker, Aashish is responsible for strategic planning and execution of marketing strategies aimed at improving patient outcomes in hemorrhagic stroke. His experience includes working on various aspects of product development, from concept to market launch, ensuring that products meet both regulatory standards and market needs.2
Aashish Bapat's professional profile can be found on LinkedIn under the username aashishbapat.1
Highlights
✈️ Just wrapped up an insightful week in the UK, visiting customers across five cities! I had the pleasure of discussing the Contour Neurovascular System and Stryker's Intrasaccular portfolio with so many dedicated professionals.
📝Particularly enjoyed the rich case discussions with physicians shaping the field. Their commitment to advancing neurovascular health is commendable.
👥 Another highlight was discussing early experience with physicians from the EEMEA region during our Contour User Meeting!
Kudos to the team for their exceptional organization! Looking forward to continued innovation and collaboration with our customers
#Contour #Intrasaccular #Neurovascular #Stryker #Innovation
Any experienced product managers interested in being on the ground floor of building point-of-care diagnostic solutions for infectious diseases? Max Perelman and team are looking for someone to own the product, extending their molecular diagnostic capabilities used by some leading universities and defense sector. Biomeme, Inc. You can apply here:
